SAH in-hospital mortality rate 1 year previously compared with 1 year during the COVID-19 pandemic
N | Overall volume | ||||
aSAH admissions | Mortality | Mortality rate (%) | P value | ||
Overall | |||||
Before COVID | 144 | 5918 | 1129 | 19.08 | 0.12 |
During COVID | 5654 | 1181 | 20.89 | ||
Hospital aSAH volume: low | |||||
Before COVID | 46 | 325 | 94 | 28.92 | 0.936 |
During COVID | 377 | 108 | 28.65 | ||
Hospital aSAH volume: medium | |||||
Before COVID | 51 | 1402 | 310 | 22.11 | 0.678 |
During COVID | 1407 | 302 | 21.46 | ||
Hospital aSAH volume: high | |||||
Before COVID | 47 | 4191 | 725 | 17.30 | 0.003 |
During COVID | 3870 | 771 | 19.90 | ||
Centre COVID-19 volume: low | |||||
Before COVID | 47 | 1772 | 293 | 16.53 | 0.872 |
During COVID | 1812 | 296 | 16.34 | ||
Centre COVID-19 volume: intermediate | |||||
Before COVID | 42 | 1421 | 296 | 20.83 | 0.116 |
During COVID | 1334 | 311 | 23.31 | ||
Centre COVID-19 volume: high | |||||
Before COVID | 41 | 2035 | 445 | 21.87 | 0.003 |
During COVID | 1907 | 495 | 25.96 |
The periods before and during COVID-19 pandemic were defined as 12 months before and during the COVID-19 pandemic, respectively.
aSAH, aneurysmal subarachnoid haemorrhage; n, number of hospitals; SAH, subarachnoid haemorrhage.